News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

U. Paulus

Articles by U. Paulus

2 Cycles of ABVD Plus Radiotherapy Is More Effective Than Radiotherapy Alone in Early Stage HD-Interim Ahan Radiotherapy Alone in Early Stage HD-Interim Analysis of the HD7 Trial of the GHSG Clinic of Internal Medicine I University of Cologne/Germany

ByH. Tesch,M. Sieber,J. U. Rüffer,J. Franklin,R. Herrmann,F. Boissevain,A. Franke,M. Pfreundschuh,D. Hossfeld,E. Dühmke,J. Wolf,A. Engert,U. Paulus,V. Diehl

March 1st 1999

BACKGROUND: Extended-field radiotherapy is effective in patients with early-stage Hodgkin’s disease, and more than

Increased Efficacy Through Moderate Dose Escalation of Chemotherapy: Interim Report From the HD9 Randomized Trial for Advanced Hodgkin’s Disease

ByV. Diehl,J. Franklin,M. Sieber,D. Hasenclever,U. Paulus,H. Tesch,M. Pfreundschuh,U. Rüffer,R. Hermann,C. Longin,M. Hänel,G. Wulf,W. Aulitzky,A. Georgii,E. Dühmke,M. Loeffler

March 1st 1999

This report aims to assess the effect of increased drug dose on the efficacy and toxicity of the BEACOPP regimen with

Latest Updated Articles

Trending on CancerNetwork

Melanoma Vaccine Receives FDA Fast Track Designation

NCCN Guidelines Recommend Taletrectinib for ROS1+ NSCLC Subtype

Targeting NAMPT and KRAS in Pancreatic Ductal Adenocarcinoma

Evaluating the Impact of Post-Diagnostic Health on Prostate Cancer Outcomes

Duvelisib Shows Significant Activity in R/R Peripheral T-Cell Lymphoma